医生收取器械厂商付款与ICD植入时器械选择的相关性
结果显示94%的植入医生接受过厂商付款,患者更可能接受向手术医生支付最高金额的厂商所生产的器械,各厂商比例使用绝对差异为14.5%至30.6%。
要点
- 94%的ICD/CRT-D植入医生接受过器械厂商付款,中位付款1211美元。
- 患者接受手术医生获付款最高厂商器械的比例为38.5%至54.7%。
- 各厂商比例使用超出预期患病率的绝对差异为14.5%至30.6%。
核心结论
- 医生收取器械厂商付款与患者接受该厂商ICD或CRT-D器械的可能性更高相关。
主要发现
- 患者接受付款最高厂商器械的比例为38.5%至54.7%。
- 比例使用超出预期患病率的绝对差异:厂商A为22.4%(95%CI 21.9%-22.9%),厂商B为14.5%(95%CI 14.0%-15.0%),厂商C为18.8%(95%CI 18.2%-19.4%),厂商D为30.6%(95%CI 30.0%-31.2%)。
临床怎么用
- 临床选择ICD或CRT-D器械时应关注医生与厂商财务关系对器械选择的潜在影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Little is known about the association between industry payments and medical device selection. OBJECTIVE: To examine the association between payments from device manufacturers to physicians and device selection for patients undergoing first-time implantation of a cardioverter-defibrillator (ICD) or cardiac resynchronization therapy-defibrillator (CRT-D). DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study, patients who received a first-time ICD or CRT-D device from any of the 4 major manufacturers (January 1, 2016-December 31, 2018) were identified. The data from the National Cardiovascular Data Registry ICD Registry was linked with the Open Payments Program's payment data. Patients were categorized into 4 groups (A, B, C, and D) corresponding to the manufacturer from which the physician who performed the implantation received the largest payment. For each patient group, the proportion of patients who received a device from the manufacturer that provided the largest payment to the physician who performed implantation was determined. Within each group, the absolute difference in proportional use of devices between the manufacturer that made the highest payment and the proportion of devices from the same manufacturer in the entire study cohort (expected prevalence) was calculated. EXPOSURES: Manufacturers' payments to physicians who performed an ICD or CRT-D implantation. MAIN OUTCOMES AND MEASURES: The primary outcome of the study was the manufacturer of the device used for the implantation. RESULTS: Over a 3-year period, 145 900 patients (median age, 65 years; 29.6% women) received ICD or CRT-D devices from the 4 manufacturers implanted by 4435 physicians at 1763 facilities. Among these physicians, 4152 (94%) received payments from device manufacturers ranging from $2 to $323 559 with a median payment of $1211 (interquartile range, $390-$3702). Between 38.5% and 54.7% of patients received devices from the manufacturers that had provided physicians with the largest payments. Patients were substantially more likely to receive devices made by the manufacturer that provided the largest payment to the physician who performed implantation than they were from each other individual manufacturer. The absolute differences in proportional use from the expected prevalence were 22.4% (95% CI, 21.9%-22.9%) for manufacturer A; 14.5% (95% CI, 14.0%-15.0%) for manufacturer B; 18.8% (95% CI, 18.2%-19.4%) for manufacturer C; and 30.6% (95% CI, 30.0%-31.2%) for manufacturer D. CONCLUSIONS AND RELEVANCE: In this cross-sectional study, a large proportion of ICD or CRT-D implantations were performed by physicians who received payments from device manufacturers. Patients were more likely to receive ICD or CRT-D devices from the manufacturer that provided the highest total payment to the physician who performed an ICD or CRT-D implantation than each other manufacturer individually.
引用
- Annapureddy AR, Henien S, Wang Y, et al. Association Between Industry Payments to Physicians and Device Selection in ICD Implantation. JAMA. 2020. PMID: 33141208. doi:10.1001/jama.2020.17436
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。